Laurus Labs

INDIA

Total Medicines

Active

Dosage Forms

Countries

Zimbabwe (17) Tanzania (15) Rwanda (12) Zambia (10) Ghana (2)

Registration Status

Registered 37

PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) 17

3 months to expiry 1

Valid 1

Dosage Forms

TABLET, COATED; ORAL 15 Tablet, Film-coated 8 Film Coated Tablets 6 Film-coated Tablets 4 Film coated tablets 4 Film Coated Tablet 3 Tablets+ Filmcoated 2 Tablets 2

Local Agents / Applicants

LAURUS LABS LIMITED 39

Laurus Labs Limited 9

Lupin Limited 1

Laurus labs Ltd 1

LAURUS LABS Limited, 2ND... 1

LAURUS LABS LIMITED, INDIA 1

Registered Medicines

Showing 16 of 56 · Page 3 of 3

Search all

Product	Form / Strength	Country	Reg. Number	Status
Emtricitabine and Tenofovir Disoproxil Fumarate tablets 200 mg/ 300 mg Emtricitabine 200 mg,Tenofovir Disoproxil Fumarate 300 mg	Tablet, Film-coated	Tanzania	TZ 19 H 0289	Registered/Compliant
Irinotecan HCl AqVida 20 mg/ml IRINOTECAN	Concentrate for solution for infusion -	Rwanda	RWANDA-FDA25/HM/0429/0061	Registered
LOPINAVIR AND RITONAVIR TABLETS USP 100 MG/ 25 MG Lopinavir and Ritonavir Tablets USP 100 mg/ 25 mg	Film coated tablets 100 mg/ 25 mg	Rwanda	Rwanda FDA-HMP-MA-0915	Registered
LOPINAVIR AND RITONAVIR TABLETS USP 200 MG/50 MG Lopinavir 200mg and Ritonavir 50mg	Film Coated Tablets 200 mg/50 mg	Rwanda	Rwanda FDA-HMP-MA-1130	Registered
LOPINAVIR; RITONAVIR LOPINAVIR; RITONAVIR	TABLET, COATED; ORAL 100; 25MG	Zimbabwe	2022/7.13/6353	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
LOPINAVIR; RITONAVIR LOPINAVIR; RITONAVIR	TABLET, COATED; ORAL 200; 50MG	Zimbabwe	2022/7.13/6352	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
Lopinavir USP and Ritonavir USP Lopinavir 100 mg,Ritonavir 25 mg	Tablet, Film-coated 100/25	Tanzania	TAN 21 HM 0057	Registered/Compliant
Lopinavir USP and Ritonavir USP Lopinavir 200 mg,Ritonavir 50 mg	Tablet, Film-coated 200/50	Tanzania	TAN 21 HM 0021	Registered/Compliant
NONE DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR ALAFENAMIDE	TABLET, COATED; ORAL 50; 300; 25MG	Zimbabwe	2025/7.13/6941	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
TENOFOVIR ALAFENAMIDE TENOFOVIR ALAFENAMIDE FUMARATE	TABLET, COATED; ORAL 25MG	Zimbabwe	2023/7.13/6496	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
TENOFOVIR DISOPROXIL FUMARATE TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL 300MG	Zimbabwe	2018/7.13/5695	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
TENOFOVIR DISOPROXIL FUMARATE FILM-COATED TABLETS Tenofovir Disoproxil Fumarate	Tenofovir Disoproxil Fumarate 300mg	Ghana	FDA/GD.233-030029	3 months to expiry
Tenofovir Alafenamide Croscarmellose Sodium(AC-DI-SOL) 10.000 mg/6 mL,Lactose Monohydrate (Supertab 30GR) 95.000 mg/6 mL,Magnesium stearate (Ligamed MF-2-V) 2.000 mg/6 mL,Microcrystalline cellulose (Pharmacel 102) 64.955 mg/6 mL,Opadry II white 85F580019 6.000 mg/6 mL,Purified Water q.s q.s,Tenofovir Alafenamide Fumarate 25 mg/6 mL	Tablet, Film-coated	Tanzania	TAN 22 HM 0257	Registered/Compliant
Tenofovir Disoproxil Fumarate 300mg + Lamivudine 300mg + Efavirenz 400mg Efavirenz 400 mg,Lamivudine 300 mg,Tenofovir Disoproxil Fumarate 300 mg	Film Coated Tablets 300 mg,400 mg	Zambia	469/007	Registered/Compliant
Tenofovir Disoproxil Fumarate Tablets 300 mg Tenofovir Disoproxil Fumarate 300 mg	Film Coated Tablets 300 mg	Zambia	469/006	Registered/Compliant
Tenofovir disoproxil fumarate Tenofovir Disoproxil Fumarate 300 mg	Tablet, Film-coated	Tanzania	TZ 18 H 0223	Registered/Compliant

Prev 1 2 3

56 products